Mammalian teeth develop as a result of signaling interactions between epithelium (derived from oral ectoderm) and mesenchyme (derived from cranial neural crest) (reviewed by
Tucker and Sharpe, 2004). As these two tissues interact, the developing tooth progresses through four stages. First, the epithelium thickens to form a placode. Next, the epithelium invaginates into the underlying mesenchyme, while the prospective dental mesenchyme condenses around it, forming a tooth bud. Subsequently, the epithelium folds and extends farther into the mesenchyme, surrounding the dental mesenchyme to form a cap and then a bell stage tooth germ.
Epithelial morphogenesis and growth of the dental mesenchyme during the cap and bell stages are thought to be controlled by signals produced by the enamel knot, a morphologically distinct region of the epithelium containing densely-packed, nonproliferating cells (reviewed by
Thesleff et al., 2001). Enamel knot activity is proposed to be mediated, at least in part, by FGF4 and FGF9, members of the fibroblast growth factor family of secreted signaling molecules. These proteins signal to the mesenchyme by activating the mesenchyme-specific “c” isoform of FGF receptors (FGFRs) and are thought to maintain
Fgf3 expression in the dental mesenchyme. In turn, FGF3 (and FGF10) signal to the epithelium, where they regulate cell proliferation and morphogenesis, by activating the epithelium-specific FGFR “b” isoform (see ). This model, which is based primarily on gain-of-function studies in organ culture and gene expression analyses, has been difficult to test genetically because inactivating each of these FGF family members individually has no effect on molar development (
Harada et al., 2002; X. Sun, I. Thesleff, and G.R.M., unpublished data; O.K. and G.R.M., unpublished observations). This is presumably because of functional redundancy between
Fgf4 and
Fgf9 in the epithelium and
Fgf3 and
Fgf10 in the mesenchyme. The finding that tooth development is arrested at the bud stage when the b isoform of FGFR2 is specifically deleted in mice supports this hypothesis (
De Moerlooze et al., 2000).
The discovery of genes that encode antagonists of FGF signaling provided new opportunities for exploring FGF function in development (reviewed by
Thisse and Thisse, 2005). The
sprouty (
spry) gene was first identified as a negative feedback regulator of FGF-mediated tracheal branching in
Drosophila. FGF signaling induces
D. spry expression, and via this effect, the FGF pathway limits the range of its own signaling activity (
Hacohen et al., 1998). Subsequent experiments showed that
D. spry also regulates epidermal growth factor (EGF) receptor and other receptor tyrosine kinase (RTK) signaling pathways (
Casci et al., 1999;
Kramer et al., 1999;
Reich et al., 1999). There are four vertebrate orthologs of
D. spry. In mice,
Spry1, Spry2, and
Spry4 are widely expressed in the embryo (
de Maximy et al., 1999;
Minowada et al., 1999;
Zhang et al., 2001). Sprouty family members have been shown to function intracellularly to negatively regulate FGF and other RTK signaling through diverse biochemical mechanisms, often via effects on the RAS-MAPK pathway, although the mechanism of Sprouty function remains controversial (reviewed by
Kim and Bar-Sagi, 2004 and
Mason et al., 2006).
Loss-of-function analyses in mice have shown that Sprouty genes are required for normal development of many organs. For example, in
Spry1-null mice there is excess budding of the Wolffian duct during kidney development due to hypersensitivity of the duct to GDNF, a ligand for the RET RTK (
Basson et al., 2005).
Spry2 nulls have several abnormalities including a severe hearing loss due to a postnatal cell fate transformation in the auditory epithelium. This defect can be partially rescued by reducing
Fgf8 gene dosage (
Shim et al., 2005), providing evidence that in this developmental context,
Spry2 affects FGF signaling.
Here, we report that although Spry2 and Spry4 are expressed in different tissue compartments during tooth development (epithelium and mesenchyme, respectively), loss of function of either gene results in the same phenotype, i.e., formation of teeth in a region, called the diastema, that is normally toothless. These will hereafter be referred to as “diastema teeth.” We suggest a model to explain how Sprouty genes function during odontogenesis to prevent development of diastema teeth, based on evidence that they serve to block FGF-mediated crosstalk between the epithelium and mesenchyme.